NEW JERSEY MEDICAL SCHOOL

THE INSTITUTE OF OPHTHALMOLOGY AND VISUAL SCIENCE

 

FROM THE ARCHIVES OF MONIQUE S. ROY, MD
  BIOGRAPHICAL SKETCH  
  TABLE: Statistical Analysis of SNPs Across the Human Genome for Association With Retinopathy (2009)  
  SELECTED ARTICLES  
     
  1. Roy M, Janal M, Roy A. Medical and psychological risk factors associated with incident hypertension in type 1 diabetic African Americans. Int J Hypertension. In press.  
     
  2. Roy A, Roy M, Janal M. Suicide attempts and ideation in type 1 diabetic patients. Psychiatry Res. In press.  
     
  3. Howson J, Roy M, Zeitels L, Stevens H, Walker N, Goldman D, Todd J. Dissections of HLA class II associations in type 1 diabetes in African Americans. Diabetologia. In press.  
     
  4. Kolomeyer AM, Roy MS, Chu DS. The use of intravitreal ranibizumab for choroidal neovascularization associated with Vogt-Koyanagi-Harada syndrome. Case Report Med. 2011;2011:747648.  
     
  5. Roy M , Klein R, Janal M. Retinal venular diameter as an early indicator of progression to proliferative diabetic retinopathy with and without high-risk characteristics in African Americans with type 1 diabetes. Arch Ophthalmol. 2011;129:8-15.  
     
 

6. Roy M, Hallman DM, Fu Y-P, Machado M, Hanis C. Assessment of 193 candidate genes for diabetic retinopathy in African-Americans with type 1 diabetes. Arch Ophthalmol 2009;127:605-12.

 
     
 

7. Pachydaki S, Klaver C, Barbazetto I, Roy M, Gouras P, Allikmets R, Yannuzzi L. Phenotypic features of patients with NR2E3 mutations. Arch Ophthalmol 2009;127;71-5.

 
     
 

8. Roy MS, Peng B. Six year incidence of lower extremity arterial disease and associated risk factors in type 1 diabetic African-Americans. Diab Med 2008;25:550-6.

 
     
 

9. Roy M, Peng B, Roy A. Risk factors for coronary disease and stroke in previously hospitalized African-Americans with type 1 diabetes: a 6-year follow-up. Diab Med 2007;24:1361-8.

 
     
  10. Roy M, Roy A, Affouf M. Depression is a risk factor for poor glycemic control and retinopathy in African-Americans with type 1 diabetes. Psychosom Med 2007;69:537-42.  
     
  11. Roy M, Affouf M, Roy A. Six-year incidence of proteinuria in type 1 diabetic African Americans. Diabetes Care 2007;30:1807-12.  
     
  12. Roy MS, Skurnick J. Six-year incidence of visual loss in African Americans with type 1 diabetes mellitus: the New Jersey 725. Arch Ophthalmol 2007;125:1061-7.  
     
  13. Roy M, Affouf M. Six-year progression of retinopathy and associated risk factors in African-Americans with type 1 diabetes: the New Jersey 725. Arch Ophthalmol 2006;124:1297-306.  
     
  14. Roy M, Rendas-Baum R, Skurnick J. Mortality in African-Americans with type 1 diabetes: the New Jersey 725. Diabetic Med 2006;23:698-706.  
     
  15. Roy M, Roy A. No relationship between cholesterol and depression and suicidal ideation in African-Americans with type 1 diabetes. Arch Suicidal Res 2006;10:11-4.  
     
  16. Roy M. Eye care in African-Americans with type 1 diabetes: the New Jersey 725. Ophthalmology 2004;111: 914-20.  
     
  17. Roy M, Klein R, O’Colmain B. The prevalence of diabetic retinopathy among adult type 1 diabetic persons in the United States. Arch Ophthalmol 2004;122:546-51.  
     
  18. Roy M. Proteinuria in African-Americans with type 1 diabetes: the New Jersey 725. J Diabetes Complications.
2004;18:69-77.
 
     
  19. Roy A, Roy M, Berman J, Gonzalez B. Cone electroretinogram amplitudes are related to dopamine function in cocaine- dependent patients. Psychiatry Res 2003;117:191-5.  
     
  20. Roy A, Berman J, Gonzalez B, Roy M. CSF monomine metabolites in cocaine patients: no relationship to cue-induced craving. J Psychopharmacol 2002;16:227-9.  
     
  21. Roy M. Frequency and risk factors associated with macular edema in African-Americans with type I diabetes: the New Jersey 725. Excerpta Medica 2002;9:7-10.  
     
  22. Smelson D, Roy A, Roy M, Habib C, Engelhart C, Losonczy M. Electroretinogram and cue elicited craving in withdrawn cocaine patients: a replication. Am J Drug Alcohol Abuse 2001;27:391-7.  
     
  23. Roy MS. Prevalence and risk factors for proteinuria in African-Americans with type 1 diabetes; relationship to diabetic retinopathy: The New Jersey 725. Invest Ophthalmol Vis Sci 2001;42(4 Suppl):S698.  
     
  24. Roy, M. Diabetic retinopathy in African-Americans with type I diabetes: The New Jersey 725. II. Risk factors. Excerpta Medica 2001;8:14.  
     
  25. Roy, M. Diabetic retinopathy in African-Americans with type I diabetes: The New Jersey 725. I. Methodology, population,frequency of retinopathy and visual impairment. Excerpta Medica 2001;8:14.  
     
  26. Roy A, Roy M. Depressive symptoms in African-American type 1 diabetics. Depression and Anxiety 2001;13:28-31.  
     
  27. Roy M, Klein R. Macular edema and retinal hard exudates in African-Americans with type 1 diabetes: the New Jersey 725. Arch Ophth 2001;119:251-9.  
     
  28. Roy M. Diabetic retinopathy in African-Americans with type 1 diabetes: the New Jersey 725. II. Risk factors. Arch Ophth 2000;118:105-15.  
     
  29. Roy M. Diabetic retinopathy in African-Americans with type 1 diabetes: the New Jersey 725: I. Methodology, population, frequency of retinopathy, and visual impairment. Arch Ophth 2000;118:97-104.  
     
  30. Abdelsalam A, Gonalez C, Del Priore L, Roy M. Unsuspected metallic intraocular foreign body associated with blurry visual acuity and depressed ERG. Invest Ophthalmol Vis Sci 2000;41(Suppl):S1838.  
     
  31. Roy M, Klein R, Parides M. Macular edema in African-Americans with type I diabetes: The New Jersey 725. Invest Ophthalmol Vis Sci 2000;41(Suppl):S3469.  
     
  32. Roy M and Borenstein M. Visual impairment in African-American with type I diabetes: the New Jersey 725. Invest Ophthalmol Vis Sci 1999;40(Suppl):S372.  
     
  33. Smelson D, Roy M, Roy A and Santana S. Electroretinogram in withdrawn cocaine-dependent patients: relationship to cue-elicited craving. Brit J Psychiatry 1998;172:537-9.  
     
  34. Roy A, Roy M, Smelson D. Risperidone, ERG and cocaine craving. Am J Addiction 1998;7:90.  
     
  35. Fleckner M, Roy M. Effect of refractive error on retinal microcirculation: a blue field simulation study. Invest Ophthalmol Vis Sci 1998;39(Suppl):S267.  
     
  36. Roy M, Borenstein M, Klein R. Treatment risk factors for diabetic retinopathy in African-American with type 1 diabetes: the New Jersey Study. Invest Ophthalmol Vis Sci 1998;39(Suppl):S193.  
     
  37. Smelson D, Roy A, Roy M. Risperidone and neuropsychological test performance in cocaine addicts. Can J Psychiatry 1997;42:431-5.  
     
  38. Smelson D, Roy A, Roy M. Risperidone and neuropsychological functioning in cocaine addicts. Can J Psychiatry 1996;42:415-21.  
     
  39. Roy M, Roy A. Abnormal ERG in cocaine-dependent patients: relationship to craving. Br J Psychiatry 1996;168:507-11.  
     
  40. Roy M, Gascon P. Macular blood flow velocity in sickle cell patients: relationship to red cell density. Br J Ophthalmol 1995;79:742-5.  
     
  41..Roy M, Roy A. Factitious hypoglycemia: an eleven-year follow-up. Psychosomatics 1995;36:1-2.  
     
  42. Roy M, Collier B, Roy A. Excess of decompressive symptoms and life events among diabetic outpatients: a preliminary study. Comp Psychiatry 1994;34:129-31.  
     
  43. Roy M, Collier B, Roy A. Plasma cortisol and ACTH levels and duration of diabetes. J Diabetic Compl 1992;5:218-20.  
     
  BOOKS, MONOGRAPHS AND CHAPTERS  
     
  1. Roy M, MacKay CJ, and Gouras P. Detecting blue cone monochromats by electroretinopathy. In: Cavonius CR, editor. Color vision deficiencies XIII. Kluwer Academic; 1997. p 409-413.  
     
  2. Gouras P, MacKay CJ, Roy M, Saeki M, and Yamamoto S. Retinal and brain responses of S-cones. In: Drum B, editor. Color vision deficiencies XII. Kluwer Academic; 1994. p 353-364.  
     

 

navigation bar: home page, staff directory, directions, UMDNJ web site UMDNJ web site directions staff directory home page  
NJMS
residency program /// patient care services /// research
ophthalmic medical assistant program /// continuing medical education
facilities /// faculty /// faqs

 

umdnj web site directions staff directory home page directions staff directory home page